Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,349,794 papers from all fields of science
Search
Sign In
Create Free Account
Involved Node Radiation Therapy
Known as:
INRT
Radiation treatment delivered only to the lymph nodes originally involved, used primarily in the treatment of Hodgkin lymphoma.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
The Pathobiology and Treatment of Hodgkin Lymphoma. Where do We go from Gianni Bonadonna's Lesson?
S. Viviani
,
V. Tabanelli
,
S. Pileri
Tumori
2017
Corpus ID: 2099418
This article reviews the evolution of the diagnosis and treatment of Hodgkin lymphoma (HL) since its discovery in 1832. The…
Expand
Review
2017
Review
2017
PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach…
L. Fornecker
,
J. Lazarovici
,
+21 authors
M. André
2017
Corpus ID: 201157891
Background: About 15-20% of patients with early-stage unfavorable Hodgkin lymphoma (HL) relapse or are refractory to first-line…
Expand
2016
2016
[Choice of initial regimen for antiretroviral-naïve HIV patients: Analysis of motivation].
E. Rouveix
,
E. Mortier
,
+10 authors
Corevih Île-de-France Ouest
La Revue de medecine interne
2016
Corpus ID: 196469085
Review
2015
Review
2015
The importance of radiotherapy on diffuse large B cell lymphoma treatment: a current review
F. Mendes
,
Cátia Domingues
,
+7 authors
M. Rosa
Cancer Metastasis Review
2015
Corpus ID: 18292151
Diffuse large B cell lymphoma is recognized as a heterogeneous group of hematological malignancies; two main subtypes germinal…
Expand
2014
2014
Radiation therapy for early stage unfavorable Hodgkin lymphoma: is dose reduction feasible?
S. Laskar
,
Deepak P. Kumar
,
+10 authors
S. Banavali
Leukemia and Lymphoma
2014
Corpus ID: 207511310
Abstract One hundred and fifty-one patients aged between 3 and 70 years with early stage unfavorable Hodgkin lymphoma were…
Expand
2014
2014
Involved-nodal radiation therapy leads to lower doses to critical organs-at-risk compared to involved-field radiation therapy.
D. Mulvihill
,
K. McMichael
,
S. Goyal
,
R. Drachtman
,
A. Weiss
,
Atif J. Khan
Radiotherapy and Oncology
2014
Corpus ID: 24257940
2011
2011
Lipid profile and plasma antioxidant status in sweet carbonated beverage-induced metabolic syndrome in rat.
M. Otero-Losada
,
D. Grana
,
A. Müller
,
G. Ottaviano
,
G. Ambrosio
,
J. Milei
International Journal of Cardiology
2011
Corpus ID: 205204949
2011
2011
Abbreviated 8-week chemotherapy (CT) plus involved node radiotherapy (INRT) for nonbulky stage I-II Hodgkin lymphoma: Preliminary results of the Stanford G5 Study.
R. Advani
,
S. Horning
,
+4 authors
R. Hoppe
Journal of Clinical Oncology
2011
Corpus ID: 31360172
8064 Background: Combined modality therapy is the standard of care for non-bulky Stage I-II HL. Currently, brief CT +30 Gy…
Expand
Review
2009
Review
2009
Involved field radiotherapy for limited stage Hodgkin lymphoma: balancing treatment efficacy against long‐term toxicities
J. Goda
,
R. Tsang
Hematological Oncology
2009
Corpus ID: 5371956
Limited stage Hodgkin lymphoma (HL) refers to patients with stage IA or IIA disease in the absence of any bulky mass or…
Expand
2007
2007
FDG-PET scan and treatment planning for early stage Hodgkin lymphoma.
L. Specht
Radiotherapy and Oncology
2007
Corpus ID: 37183437
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE